Bright Green (BGXX) Competitors $0.06 -0.01 (-7.98%) As of 03/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BGXX vs. GBIO, ATHE, OVID, IRD, PLUR, COEP, CLNN, LEXX, MRNS, and PASGShould you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include Generation Bio (GBIO), Alterity Therapeutics (ATHE), Ovid Therapeutics (OVID), Opus Genetics (IRD), Pluri (PLUR), Coeptis Therapeutics (COEP), Clene (CLNN), Lexaria Bioscience (LEXX), Marinus Pharmaceuticals (MRNS), and Passage Bio (PASG). These companies are all part of the "pharmaceutical products" industry. Bright Green vs. Generation Bio Alterity Therapeutics Ovid Therapeutics Opus Genetics Pluri Coeptis Therapeutics Clene Lexaria Bioscience Marinus Pharmaceuticals Passage Bio Bright Green (NASDAQ:BGXX) and Generation Bio (NASDAQ:GBIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk. Which has more volatility & risk, BGXX or GBIO? Bright Green has a beta of -0.26, meaning that its stock price is 126% less volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.72, meaning that its stock price is 172% more volatile than the S&P 500. Which has stronger valuation & earnings, BGXX or GBIO? Bright Green has higher earnings, but lower revenue than Generation Bio. Bright Green is trading at a lower price-to-earnings ratio than Generation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright GreenN/AN/A-$13.13M-$0.06-1.00Generation Bio$19.89M1.54-$126.61M-$1.98-0.23 Is BGXX or GBIO more profitable? Bright Green has a net margin of 0.00% compared to Generation Bio's net margin of -782.86%. Bright Green's return on equity of -88.37% beat Generation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Bright GreenN/A -88.37% -55.30% Generation Bio -782.86%-104.85%-49.54% Does the MarketBeat Community believe in BGXX or GBIO? Generation Bio received 46 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformBright GreenN/AN/AGeneration BioOutperform Votes4671.88% Underperform Votes1828.13% Does the media favor BGXX or GBIO? In the previous week, Generation Bio had 2 more articles in the media than Bright Green. MarketBeat recorded 3 mentions for Generation Bio and 1 mentions for Bright Green. Bright Green's average media sentiment score of 0.00 beat Generation Bio's score of -0.04 indicating that Bright Green is being referred to more favorably in the media. Company Overall Sentiment Bright Green Neutral Generation Bio Neutral Do institutionals and insiders hold more shares of BGXX or GBIO? 7.8% of Bright Green shares are held by institutional investors. Comparatively, 95.2% of Generation Bio shares are held by institutional investors. 62.5% of Bright Green shares are held by insiders. Comparatively, 21.1% of Generation Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts recommend BGXX or GBIO? Generation Bio has a consensus price target of $7.33, suggesting a potential upside of 1,505.02%. Given Generation Bio's stronger consensus rating and higher probable upside, analysts plainly believe Generation Bio is more favorable than Bright Green.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Green 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Generation Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryGeneration Bio beats Bright Green on 10 of the 16 factors compared between the two stocks. Remove Ads Get Bright Green News Delivered to You Automatically Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGXX vs. The Competition Export to ExcelMetricBright GreenMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.47M$1.12B$5.64B$8.06BDividend YieldN/AN/A4.57%4.01%P/E Ratio-1.009.6823.1319.03Price / SalesN/A6.23383.8993.17Price / CashN/A10.4038.1634.64Price / Book1.001.236.944.33Net Income-$13.13M-$53.09M$3.20B$247.06M7 Day PerformanceN/A-0.16%-2.32%-0.37%1 Month PerformanceN/A-14.60%2.84%-3.85%1 Year PerformanceN/A-41.11%10.75%1.27% Bright Green Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGXXBright GreenN/A$0.06-8.0%N/A-76.6%$11.47MN/A-1.002Gap UpGBIOGeneration Bio4.0017 of 5 stars$0.47-4.4%$7.33+1,447.1%-87.7%$31.76M$19.89M-0.22150Short Interest ↓Gap UpATHEAlterity Therapeutics2.7487 of 5 stars$3.58+1.0%$12.00+235.7%+76.2%$31.70MN/A0.0010Short Interest ↓News CoverageOVIDOvid Therapeutics4.5317 of 5 stars$0.44-0.3%$3.03+584.7%-87.6%$31.49M$566,000.00-0.9460Analyst RevisionIRDOpus Genetics2.3461 of 5 stars$1.00-13.5%$8.00+704.0%N/A$31.41M$8.38M-0.9114High Trading VolumePLURPluri1.0091 of 5 stars$4.47+2.1%N/A-38.1%$31.28M$678,000.00-0.80150Short Interest ↓COEPCoeptis Therapeutics0.8165 of 5 stars$9.47+0.6%N/A+56.7%$30.69MN/A-1.632Positive NewsCLNNClene3.5508 of 5 stars$3.68-6.0%$55.25+1,399.7%-62.6%$30.60M$421,000.00-0.70100Earnings ReportShort Interest ↓Analyst RevisionNews CoverageLEXXLexaria Bioscience3.2182 of 5 stars$1.74-1.1%$7.00+302.3%-52.8%$30.54M$496,923.00-3.487Gap UpMRNSMarinus Pharmaceuticals2.3685 of 5 stars$0.55-0.2%$4.79+771.6%-93.8%$30.32M$30.99M-0.22110Analyst ForecastNews CoveragePASGPassage Bio3.2884 of 5 stars$0.48-3.6%$7.50+1,456.0%-68.5%$29.96MN/A-0.41130Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies GBIO Alternatives ATHE Alternatives OVID Alternatives IRD Alternatives PLUR Alternatives COEP Alternatives CLNN Alternatives LEXX Alternatives MRNS Alternatives PASG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGXX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Green Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Green With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGXX Stock Free BGXX Stock Alerts